|
|
|
| Webinar: Flexible Therapeutic Development: Balancing Speed, Cost, and Process | Behind every molecule is a unique development strategy. In this webinar, KBI Biopharma showcases its flexible microbial protein platforms designed to accelerate first-in-human programs with speed, cost-efficiency, and process robustness. Explore considerations in cell line development, fermentation, and purification, and learn how platform-based approaches and robotic workflows align milestones from proof-of-concept through toxicology material generation with no license fee to evaluate. Click here to learn more. |
|
|
|
|
|
| 5 Advantages Of Dual-Sourcing In Pharmaceutical Fill/Finish | Article | Argonaut Manufacturing Services | Delve into the specific advantages of dual-sourcing in pharmaceutical fill/finish, exploring how this approach can bolster supply chain resilience, increase capacity, and accelerate commercialization. |
|
|
|
|
By Jeffrey S. Buguliskis, Ph.D., deputy chief editor, Outsourced Pharma | As biopharma pipelines shift toward more complex therapies, sponsors are finding that CDMO readiness now depends less on general capacity and more on highly specific technical capabilities. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
| Unravelling The Complexities Of ADC Manufacturing | White Paper | Pfizer CentreOne | Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide. |
|
|
| 4 Things To Consider In Pharmaceutical Labeling | Article | HERMA | Pharmaceutical labeling demands precision. Examine key considerations for ensuring accuracy and efficiency in your process, from robust control systems to diverse printing options. |
|
|
| Unlock The Potential Of Pharmacovigilance Outsourcing | White Paper | Cencora | Outsourcing pharmacovigilance can reduce overhead, strengthen compliance, and free teams to focus on innovation. Examine what a well-structured global PV model actually looks like in practice. |
|
|
|
| The Challenges Of Moving A Bioconjugate From Clinic To Market | Article | By Iwan Bertholjotti and Dr. Bernhard Stump, Lonza | Working with a partner that provides a one-stop shop for bioconjugate development and manufacturing helps prevent missteps that threaten the delivery of life-saving drugs to patients who need them. |
|
|
| Therapeutic mAb And Fab Fragment Characterization | Poster | Catalent | Size homogeneity of a mAb in solution is crucial for comparability and characterization. Here, an IgG1 antibody was cleaved into antigen-binding fragments via pepsin and papain digestion, then purified. |
|
|
|
End-To-End Services: Discovery To Commercialization | ProBio | Comprehensive global services accelerate biologics and cell therapy development, offering discovery, GMP manufacturing, and advanced platforms for efficient preclinical, clinical, and commercial stages. |
|
|
|
You Make The Discovery. We Help Make It Reality. | Avid Bioservices | Transforming the CDMO experience means treating your molecule's journey from development to commercial supply with unmatched expertise, world-class facilities, and quality-driven partnership. |
|
|
Large-Scale Cell Culture Multi-Product Facility | Boehringer Ingelheim Biopharmaceuticals GmbH | With cutting-edge innovations like smart glasses for live process insights and a data-sharing portal, we're able to provide the capacity and expertise to bring biologics to commercial success. |
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
